EPISODE · Nov 24, 2025 · 15 MIN
479. 肾脏损伤逆转与慢性肾病治疗新进展
from 知为谁 · host 知为谁
这篇来自《国家地理》的文章讨论了慢性肾脏疾病 (CKD) 治疗的重大突破，这些突破为患者带来了治愈的希望。文章指出，新型药物，特别是最初用于治疗 2 型糖尿病的 GLP-1 受体激动剂（如 Ozempic 和 Mounjaro），正在临床试验中展现出显著疗效，能够稳定甚至逆转肾脏损伤。文章还通过一个名叫 Nicolas Palacios 的患者的个人经历，强调了这些新疗法带来的生活质量的巨大改善，使其免于透析或肾移植的未来。总而言之，目前科学界正处于肾脏病研究的“黄金时代”，这使得从疾病缓解走向彻底治愈成为一个现实的可能性。内容来源： https://www.nationalgeographic.com/health/article/chronic-kidney-disease-medical-breakthroughs
Embed this episode
Ready to play
479. 肾脏损伤逆转与慢性肾病治疗新进展
0:00
15:42
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 知为谁?
This episode is 15 minutes long.
When was this 知为谁 episode published?
This episode was published on November 24, 2025.
Can I download this 知为谁 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!